AYTU BIOPHARMA, INC Annual Operating Lease, Payments in USD from 2020 to 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use.
Summary
Aytu Biopharma, Inc quarterly/annual Operating Lease, Payments history and growth rate from 2020 to 2024.
  • Aytu Biopharma, Inc Operating Lease, Payments for the quarter ending September 30, 2024 was $168K, a 53.3% decline year-over-year.
  • Aytu Biopharma, Inc annual Operating Lease, Payments for 2024 was $1.81M, a 26.2% increase from 2023.
  • Aytu Biopharma, Inc annual Operating Lease, Payments for 2023 was $1.44M, a 41.3% increase from 2022.
  • Aytu Biopharma, Inc annual Operating Lease, Payments for 2022 was $1.02M, a 118% increase from 2021.
Operating Lease, Payments, Annual (USD)
Operating Lease, Payments, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2024 $1.81M +$376K +26.2% Jul 1, 2023 Jun 30, 2024 10-K 2024-09-26
2023 $1.44M +$420K +41.3% Jul 1, 2022 Jun 30, 2023 10-K 2024-09-26
2022 $1.02M +$549K +118% Jul 1, 2021 Jun 30, 2022 10-K 2023-10-12
2021 $467K +$268K +135% Jul 1, 2020 Jun 30, 2021 10-K 2022-09-27
2020 $199K Jul 1, 2019 Jun 30, 2020 10-K 2021-09-28
* An asterisk sign (*) next to the value indicates that the value is likely invalid.